BluePath Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

BluePath Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	+2,281	New	+$1.09M	0.63%	65
2024 Q4	–	Sell	-389	Closed	-$241K	–	110
2024 Q3	$241K	Buy	389 +11	+3%	+$6.51K	0.15%	93
2024 Q2	$209K	Sell	378 -50	-12%	-$28.6K	0.15%	104
2024 Q1	$249K	Buy	428 +58	+16%	+$32.5K	0.19%	104
2023 Q4	$201K	Buy	370 +51	+16%	+$24.7K	0.17%	102
2023 Q3	$161K	Buy	+319	New	+$170K	0.15%	113

Other funds holding TMO

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

BluePath Capital Management's TMO Position: Q2 2026 in Review

BluePath Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 2,281 shares worth $1.14M. The stake represents 0.63% of the portfolio and ranks #65 among its holdings. This is a return to the name: BluePath Capital Management previously reported a position in TMO as recently as Q3 2024.

BluePath Capital Management first reported a position in TMO in Q3 2023 and has held it in 6 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

BluePath Capital Management held 2,281 shares of Thermo Fisher Scientific worth $1.14M as of Q2 2026.
Thermo Fisher Scientific was a new BluePath Capital Management position in Q2 2026.
Thermo Fisher Scientific made up 0.63% of BluePath Capital Management's portfolio in Q2 2026, its #65 holding.
BluePath Capital Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 6 quarters since.
794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.